프리비아 헬스 그룹, Inc.
US ˙ NasdaqGS ˙ US74276R1023

SecurityPRVA / Privia Health Group, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in PRVA / Privia Health Group, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Privia Health Group, Inc. (US:PRVA). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-07-10 , Vanguard Group Inc had reported owning 11,933,031 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 11,933,031 0 -100.00 0.00 -100.00
2024-07-10 2024-07-10 13G/A 11,278,334 11,933,031 5.80 10.00 4.71
2024-02-13 2024-02-13 13G 11,278,334 9.55

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F PRIVIA HEALTH GROUP COM 74276R102 11,995,970 -102,963 -0.85 284,424 -5.59 0.0041
2025-11-07 2025-09-30 13F PRIVIA HEALTH GROUP COM 74276R102 12,098,933 607,447 5.29 301,263 13.98 0.0045
2025-08-11 2025-06-30 13F PRIVIA HEALTH GROUP COM 74276R102 11,491,486 218,928 1.94 264,304 4.44 0.0043
2025-05-09 2025-03-31 13F PRIVIA HEALTH GROUP COM 74276R102 11,272,558 -149,152 -1.31 253,069 13.33 0.0046
2025-02-11 2024-12-31 13F PRIVIA HEALTH GROUP COM 74276R102 11,421,710 -419,169 -3.54 223,294 3.56 0.0039
2024-11-13 2024-09-30 13F PRIVIA HEALTH GROUP COM 74276R102 11,840,879 -92,152 -0.77 215,622 3.97 0.0039
2024-08-13 2024-06-30 13F PRIVIA HEALTH GROUP COM 74276R102 11,933,031 532,996 4.68 207,396 -7.13 0.0040
2024-05-10 2024-03-31 13F PRIVIA HEALTH GROUP COM 74276R102 11,400,035 121,701 1.08 223,327 -14.02 0.0044
2024-03-11 2023-12-31 13F/A-1 PRIVIA HEALTH GROUP COM 74276R102 11,278,334 274,345 2.49 259,740 2.63 0.0057
2024-02-14 2023-12-31 13F PRIVIA HEALTH GROUP COM 74276R102 11,278,334 274,345 259,740 0.0049
2023-12-18 2023-09-30 13F/A-1 PRIVIA HEALTH GROUP COM 74276R102 11,003,989 51,317 0.47 253,092 -11.50 0.0062
2023-11-14 2023-09-30 13F PRIVIA HEALTH GROUP COM 74276R102 11,003,989 51,317 253,092 0.0011
2023-08-14 2023-06-30 13F PRIVIA HEALTH GROUP COM 74276R102 10,952,672 5,407,693 97.52 285,974 86.79 0.0068
2023-07-14 2023-03-31 13F/A-1 PRIVIA HEALTH GROUP COM 74276R102 5,544,979 102,711 1.89 153,097 23.87 0.0039
2023-05-15 2023-03-31 13F PRIVIA HEALTH GROUP COM 74276R102 5,544,979 102,711 153,097 0.0008
2023-02-10 2022-12-31 13F PRIVIA HEALTH GROUP COM 74276R102 5,442,268 617,544 12.80 123,594 -24.79 0.0034
2022-11-14 2022-09-30 13F PRIVIA HEALTH GROUP COM 74276R102 4,824,724 321,734 7.14 164,331 25.32 0.0048
2022-08-12 2022-06-30 13F PRIVIA HEALTH GROUP COM 74276R102 4,502,990 247,109 5.81 131,127 15.27 0.0037
2022-05-13 2022-03-31 13F PRIVIA HEALTH GROUP COM 74276R102 4,255,881 593,178 16.20 113,759 20.06 0.0027
2022-02-14 2021-12-31 13F PRIVIA HEALTH GROUP COM 74276R102 3,662,703 -464,043 -11.24 94,755 -2.54 0.0022
2021-11-12 2021-09-30 13F PRIVIA HEALTH GROUP COM 74276R102 4,126,746 -2,448,757 -37.24 97,226 -66.68 0.0024
2021-08-13 2021-06-30 13F PRIVIA HEALTH GROUP COM 74276R102 6,575,503 6,575,503 291,754 0.0073
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.